---
$id: https://graph.org.ai/products/commodity/51131644
$type: Product
source: UNSPSC
code: "51131644"
title: "Melagatran"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Melagatran

**UNSPSC Code**: 51131644
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent with the molecular formula C22H31N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2A9QP32MD4, chemically known as glycine, n-(2-(2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-, (s-(r*,s*))- but generally known as melagatran, which bears US NIH Compound Identifier 183797. European Medicines Agency schedules Melagatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08718MIG. The term MELAGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules melagatran in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule melagatran under HS 29339990 and SITC 51577. As of Q4 2014, MELAGATRAN remains the US FDA Preferred Term for this commodity. Melagatran bears US NLM identifiers UMLS ID C0668961 and NCI Concept Code C66077. SMILES: O=C(N1C(CC1)C(=O)NCC1CCC(CC1)C(=N)N)C(NCC(=O)O)C1CCCCC1.

